Compare ZKH & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ZKH | YDES |
|---|---|---|
| Founded | 1998 | 2013 |
| Country | China | Taiwan |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 465.1M | 543.0M |
| IPO Year | 2022 | 2024 |
| Metric | ZKH | YDES |
|---|---|---|
| Price | $2.92 | $4.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 111.6K | 42.4K |
| Earning Date | 05-19-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.02 | N/A |
| Revenue Next Year | $10.41 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.92 | $1.70 |
| 52 Week High | $3.90 | $25.00 |
| Indicator | ZKH | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 53.65 | 78.79 |
| Support Level | $2.88 | $4.73 |
| Resistance Level | $2.98 | $5.36 |
| Average True Range (ATR) | 0.10 | 0.48 |
| MACD | -0.01 | 0.28 |
| Stochastic Oscillator | 76.81 | 92.58 |
ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. Majority of the revenues are derived from the PRC.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.